{"public_id":"cl_7fd6f9dd86c641257c02b35bdc9bc826","status":"active","superseded_by_public_id":null,"corpus_id":6241664,"text":"Clinical trials of agents targeting LAG-3 are reviewed alongside its function in cancer and its correlation with other checkpoints.","confidence":0.94,"paper":{"corpus_id":6241664,"title":"Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer","url":"https://sah.borca.ai/papers/6241664"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.94,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_a11f2be5c6f5b23f6f0902d4b01bd91a","name":"LAG-3","description":"Lymphocyte-activation gene-3, an immune checkpoint molecule implicated in antitumor immune regulation.","types":["immune checkpoint"],"url":"https://sah.borca.ai/concepts/co_a11f2be5c6f5b23f6f0902d4b01bd91a"},{"public_id":"co_af94c501314ad00f24698a04b3b1e397","name":"other checkpoints","description":"Additional immune checkpoint targets considered for combined inhibition with LAG-3.","types":["immune checkpoint"],"url":"https://sah.borca.ai/concepts/co_af94c501314ad00f24698a04b3b1e397"},{"public_id":"co_b9ecd43b34941e1a6e929c46d40213ae","name":"clinical trials","description":"Human studies evaluating agents targeting LAG-3.","types":["study type"],"url":"https://sah.borca.ai/concepts/co_b9ecd43b34941e1a6e929c46d40213ae"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_7fd6f9dd86c641257c02b35bdc9bc826"}